ANTI-EGFR ANTIBODY DRUG CONJUGATES

The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs.

Saved in:
Bibliographic Details
Main Authors SULLIVAN, Gerard M, SOUERS, Andrew J, TAO, Zhi-fu, DOHERTY, George, BRUNCKO, Milan, BOGHAERT, Erwin R, JUDD, Andrew A, SONG, Xiaohong, FREY, Robin R, PHILLIPS, Andrew C
Format Patent
LanguageEnglish
French
German
Published 06.10.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs.
Bibliography:Application Number: EP20210158369